Sample results
Ovarian cancer is a malignant tumor that develops in the ovaries, often detected in advanced stages. It is caused by abnormal cell growth in ovarian tissue, with genetic mutations such as BRCA1 and BRCA2 significantly increasing risk. The CA-125 blood test is the most important biomarker for monitoring ovarian cancer and assessing treatment response.
Ovarian cancer is caused by abnormal cell growth in the ovaries, where cells multiply uncontrollably and form tumors. Genetic mutations play a significant role, with inherited changes in the BRCA1 and BRCA2 genes accounting for about 10-15% of ovarian cancers. Other contributing factors include age (most cases occur after menopause), family history of ovarian or breast cancer, endometriosis, obesity, and never having been pregnant. Hormone replacement therapy and certain fertility treatments may also increase risk.
The CA-125 blood test is the most important biomarker for monitoring ovarian cancer because it detects elevated levels of the CA-125 protein, which is often increased in women with ovarian cancer. This test is particularly valuable for tracking treatment response and detecting cancer recurrence in patients with confirmed ovarian cancer. However, CA-125 alone cannot diagnose ovarian cancer definitively, as elevated levels can occur in benign conditions like endometriosis, pelvic inflammatory disease, and even during menstruation. For comprehensive evaluation, the CA-125 test is typically used alongside transvaginal ultrasound and pelvic examination. In some cases, additional tumor markers like CA 19-9, CA 15-3, and CA 27.29 may provide supplementary information when used as part of a broader biomarker panel.
You should get tested if you experience persistent symptoms that last more than two weeks, including bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, and urinary urgency or frequency. Women with a strong family history of ovarian or breast cancer, especially those with BRCA1 or BRCA2 gene mutations, should discuss regular screening with their healthcare provider. Additionally, consider testing if you have a personal history of breast cancer, endometriosis, or Lynch syndrome, or if you notice unusual changes in your menstrual cycle or unexplained weight loss. Early detection significantly improves treatment outcomes, so do not ignore persistent symptoms that seem unusual for you.
What this means
Your CA-125 level is slightly elevated above the normal range. While this can be associated with ovarian cancer, it's important to know that many benign conditions like endometriosis, fibroids, or even menstruation can cause elevations. Your doctor will likely recommend additional imaging or evaluation to determine the cause.
Recommended actions
Schedule a follow-up appointment with your gynecologist or healthcare provider to discuss these results
Your doctor may recommend pelvic ultrasound or CT imaging for further evaluation
Keep track of any symptoms like pelvic pain, bloating, or changes in your cycle
Consider retesting in 4-8 weeks to see if levels change or if this is a temporary elevation
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
Sample results
Your 24/7 Personal Lab Guide
Quick questions: